Clinical trials
Recruiting Metabolic Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
121 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2010 | 1 |
| 2015 | 3 |
| 2016 | 3 |
| 2017 | 3 |
| 2019 | 5 |
| 2020 | 7 |
| 2021 | 10 |
| 2022 | 9 |
| 2023 | 12 |
| 2024 | 29 |
| 2025 | 18 |
| 2026 | 17 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 121 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Human Genome Research Institute (NHGRI) | 5 |
| Colorado State University | 3 |
| University of Michigan | 3 |
| Washington University School of Medicine | 3 |
| 89bio, Inc. | 2 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 2 |
| KK Women's and Children's Hospital | 2 |
| Massachusetts General Hospital | 2 |
| ModernaTX, Inc. | 2 |
| Ruijin Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Diseases | 121 |
| Obesity | 22 |
| Cardiovascular Diseases | 21 |
| Diabetes Mellitus | 19 |
| Glucose Metabolism Disorders | 14 |
| Diabetes Mellitus, Type 2 | 13 |
| Endocrine System Diseases | 13 |
| Insulin Resistance | 11 |
| Genetic Diseases, Inborn | 9 |
| Metabolism, Inborn Errors | 8 |
Trials
Showing 26 to 50 of 121. Each trial links to its page on Pharma Observatory.
21 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.